These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 15178578)
1. FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Angelini DF; Borsellino G; Poupot M; Diamantini A; Poupot R; Bernardi G; Poccia F; Fournié JJ; Battistini L Blood; 2004 Sep; 104(6):1801-7. PubMed ID: 15178578 [TBL] [Abstract][Full Text] [Related]
2. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen. Lafont V; Liautard J; Liautard JP; Favero J J Immunol; 2001 Jun; 166(12):7190-9. PubMed ID: 11390467 [TBL] [Abstract][Full Text] [Related]
3. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399 [TBL] [Abstract][Full Text] [Related]
4. Proinflammatory Vδ2+ T cells populate the human intestinal mucosa and enhance IFN-γ production by colonic αβ T cells. McCarthy NE; Bashir Z; Vossenkämper A; Hedin CR; Giles EM; Bhattacharjee S; Brown SG; Sanders TJ; Whelan K; MacDonald TT; Lindsay JO; Stagg AJ J Immunol; 2013 Sep; 191(5):2752-63. PubMed ID: 23904167 [TBL] [Abstract][Full Text] [Related]
5. Porcine T lymphocytes and NK cells--an update. Gerner W; Käser T; Saalmüller A Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948 [TBL] [Abstract][Full Text] [Related]
6. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells. Koyasu S J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719 [TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells. Fisher JP; Yan M; Heuijerjans J; Carter L; Abolhassani A; Frosch J; Wallace R; Flutter B; Capsomidis A; Hubank M; Klein N; Callard R; Gustafsson K; Anderson J Clin Cancer Res; 2014 Nov; 20(22):5720-32. PubMed ID: 24893631 [TBL] [Abstract][Full Text] [Related]
9. Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. Ebert LM; Meuter S; Moser B J Immunol; 2006 Apr; 176(7):4331-6. PubMed ID: 16547270 [TBL] [Abstract][Full Text] [Related]
10. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease. Angelini DF; Zambello R; Galandrini R; Diamantini A; Placido R; Micucci F; Poccia F; Semenzato G; Borsellino G; Santoni A; Battistini L J Leukoc Biol; 2011 Jan; 89(1):75-84. PubMed ID: 20952657 [TBL] [Abstract][Full Text] [Related]
11. TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells. Li H; Luo K; Pauza CD J Immunol; 2008 Nov; 181(10):7131-7. PubMed ID: 18981134 [TBL] [Abstract][Full Text] [Related]
12. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Rothenfusser S; Hornung V; Krug A; Towarowski A; Krieg AM; Endres S; Hartmann G Eur J Immunol; 2001 Dec; 31(12):3525-34. PubMed ID: 11745372 [TBL] [Abstract][Full Text] [Related]
14. Human gamma delta T cells: candidates for the development of immunotherapeutic strategies. Beetz S; Marischen L; Kabelitz D; Wesch D Immunol Res; 2007; 37(2):97-111. PubMed ID: 17695246 [TBL] [Abstract][Full Text] [Related]
15. Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity. Spencer CT; Abate G; Blazevic A; Hoft DF J Immunol; 2008 Oct; 181(7):4471-84. PubMed ID: 18802050 [TBL] [Abstract][Full Text] [Related]
16. Activation of V gamma 9V delta 2 T cells by NKG2D. Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780 [TBL] [Abstract][Full Text] [Related]
17. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17. Moens E; Brouwer M; Dimova T; Goldman M; Willems F; Vermijlen D J Leukoc Biol; 2011 May; 89(5):743-52. PubMed ID: 21330350 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Ryan PL; Sumaria N; Holland CJ; Bradford CM; Izotova N; Grandjean CL; Jawad AS; Bergmeier LA; Pennington DJ Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14378-14383. PubMed ID: 27911793 [TBL] [Abstract][Full Text] [Related]
19. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee HG; Boon T; Coulie P; van der Bruggen P Eur J Immunol; 1997 Dec; 27(12):3368-79. PubMed ID: 9464825 [TBL] [Abstract][Full Text] [Related]
20. Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes. Favier B; Espinosa E; Tabiasco J; Dos Santos C; Bonneville M; Valitutti S; Fournié JJ J Immunol; 2003 Nov; 171(10):5027-33. PubMed ID: 14607899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]